Entrada Therapeutics, Inc. - Common Stock - Çeyreklik Bilanço (NASDAQ:TRDA) | MetaTrader

Tam grafiği aç Full chart

Haberler

Entrada Therapeutics, Inc. (TRDA) Q1 2026 Earnings Call Transcript

Sarepta Dives; Can 2026 Be The Reset Year For Its Controversial Gene Therapy?

Entrada Therapeutics, Inc. (TRDA) Reports Q1 Loss, Misses Revenue Estimates

Entrada Therapeutics Perşembe günü faz 1/2 deneme verilerini açıklayacak

Entrada Therapeutics (TRDA) Surges 8.9%: Is This an Indication of Further Gains?

Entrada Therapeutics yöneticisi 229.953 dolar değerinde hisse sattı

Entrada Therapeutics Ar-Ge başkanı 398.809 dolar değerinde hisse sattı

Travere Therapeutics (TVTX) Reports Q1 Loss, Misses Revenue Estimates

Entrada Therapeutics kazancı $0,04 ile beklentilere göre daha iyi, kâr ise beklentilere göre düşük

Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Repligen (RGEN) Tops Q4 Earnings and Revenue Estimates